Tianxing Zeng

Current and emerging immunotherapeutic approaches for biliary tract cancers.

Zhen-gang Yuan, C. Tao, Tianxing Zeng, 2022, Hepatobiliary & pancreatic diseases international : HBPD INT.

Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer

Dong-sheng Chen, Wei Wei, Zhuo Cheng, 2023, Nature Communications.

Bortezomib in previously treated phosphatase and tension homology‐deficient patients with advanced intrahepatic cholangiocarcinoma: An open‐label, prospective and single‐centre phase II trial

Ye-Xiong Tan, T. Jiang, Tianxing Zeng, 2024, Clinical and translational medicine.